Susceptibility to typhoid fever is associated with a polymorphism in the cystic fibrosis transmembrane conductance regulator (CFTR)
- 3 August 2005
- journal article
- Published by Springer Nature in Human Genetics
- Vol. 118 (1) , 138-140
- https://doi.org/10.1007/s00439-005-0005-0
Abstract
The cystic fibrosis transmembrane conductance regulator (CFTR) is the affected protein in cystic fibrosis (CF). The high rate of CF carriers has led to speculation that there must be, similar to the sickle cell haemoglobin advantage in malaria, a selective advantage for heterozygotes. Such a selective advantage may be conferred through reduced attachment of Salmonella typhi to intestinal mucosa, thus providing resistance to typhoid fever. We tested this hypothesis by genotyping patients and controls in a typhoid endemic area in Indonesia for two highly polymorphic markers in CFTR and the most common CF mutation. We found an association between genotypes in CFTR and susceptibility to typhoid fever (OR=2.6). These analyses suggest that the role CFTR plays in vitro in S. typhi infection is also important for infection in the human population.Keywords
This publication has 11 references indexed in Scilit:
- Premarital and prenatal screening for cystic fibrosis: Experience in the Ashkenazi Jewish populationGenetics in Medicine, 2004
- The Type IVB Pili of Salmonella enterica Serovar Typhi Bind to the Cystic Fibrosis Transmembrane Conductance RegulatorInfection and Immunity, 2003
- Clinical profile and frequency of delta f508 mutation in Indian children with cystic fibrosis.2003
- Salmonella typhi uses CFTR to enter intestinal epithelial cellsNature, 1998
- The Estimated Incidence of Cystic Fibrosis in JapanJournal of Pediatric Gastroenterology and Nutrition, 1997
- Role of Mutant CFTR in Hypersusceptibility of Cystic Fibrosis Patients to Lung InfectionsScience, 1996
- Haplotype analysis of 94 cystic fibrosis mutations with seven polymorphicCFTR DNA markersHuman Mutation, 1996
- Cystic Fibrosis Heterozygote Resistance to Cholera Toxin in the Cystic Fibrosis Mouse ModelScience, 1994
- Cystic fibrosis patients from the black sea region: The 1677delTA mutationHuman Mutation, 1994
- A TEST OF THE HETEROZYGOTE-ADVANTAGE HYPOTHESIS IN CYSTIC-FIBROSIS CARRIERS1988